464 filings
8-K
OCUP
Ocuphire Pharma Inc
13 Jun 24
Amendments to Articles of Incorporation or Bylaws
4:06pm
DEFR14A
OCUP
Ocuphire Pharma Inc
30 May 24
Revised proxy
4:25pm
10-Q
2024 Q1
OCUP
Ocuphire Pharma Inc
Quarterly report
10 May 24
4:35pm
8-K
OCUP
Ocuphire Pharma Inc
10 May 24
Regulation FD Disclosure
4:30pm
8-K
OCUP
Ocuphire Pharma Inc
10 May 24
Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update
8:12am
ARS
jd7ors
29 Apr 24
Annual report to shareholders
4:45pm
DEFA14A
63crxvuul
29 Apr 24
Additional proxy soliciting materials
4:43pm
8-K
3wan35
17 Apr 24
Departure of Directors or Certain Officers
4:23pm
8-K
o24oc4ad
27 Mar 24
Regulation FD Disclosure
4:26pm
8-K
z183veor84kuoivk
8 Mar 24
Ocuphire Pharma Announces Financial Results for Fourth Quarter and Full Year 2023 and Provides Corporate Update
8:21am
424B3
ptt10
16 Feb 24
Prospectus supplement
4:31pm
8-K
89s8fhnpnnvx27 wq
16 Feb 24
Ocuphire Pharma Strengthens Leadership Team with Key Appointments
4:03pm
EFFECT
h7ok2p1
24 Jan 24
Notice of effectiveness
12:15am
CORRESP
52k 7dcp2ndb
22 Jan 24
Correspondence with SEC
12:00am
UPLOAD
uav8rw
19 Jan 24
Letter from SEC
12:00am
S-8
u96yw7
11 Jan 24
Registration of securities for employees
4:16pm